Transcript NIS Overview

NIS Linkages :A Policy
Perspective
Presentation by
NIRAJ KUMAR
National Project Head (IMTT)
Centre for International Trade in Technology
Indian Institute of Foreign Trade ,New Delhi
(Ministry of Commerce, GOVT OF INDIA)
NIS Overview
NIS past trends
NIS developments
NIS models
NIC Index-cross country
Linkages sub index-cross country
NIC index and sub index-INDIA
Actors and Linkages in NIS
NIS-past trends
Freeman(1987)
Dosi et al (1988)
Lundvall(1992)
Nelson(1993)
Ohmae(1995)
Edquist(1997)
Malerba(1997)
Braczyk et al(1998)
Porter(1998)
Porter and Stern(2002)
NIS-developments
Ohmae(1995)-concept of regional
innovation systems
Malerba(1997)-sectoral innovation
systems
Porter(1998)-concept of industrial
clusters
NIS-models
Liu and White(2001)-conceptual framework built on 5 different
activities of innovation process.
Research,production,enduse,linkage and education.
Chang and Shih(2003)-model made up of 6 elements.
R&D expenditure,R&D performance, Technology policy, human
capital development, technology
transfer,entrepreneurial climate.
Furman et al(2002)-concept of NIC
Porter and Stern(2002)-development of NIC Index based on 4 sub
indexes namely-innovation policy, cluster innovation, proportion of
scientists and engineers & linkages.
NIC Index-cross country
Country
US
Germany
UK
Japan
Singapore
Taiwan
Korea
India
China
Thailand
Malaysia
Rank
1
3
4
12
13
14
23
38
43
46
52
Index
30.3
27.2
27.0
26.4
26.0
26.0
22.9
18.9
18.1
17.4
16.8
Linkages sub Index-cross country
Country
US
Germany
UK
Japan
Singapore
Taiwan
Korea
India
China
Thailand
Malaysia
Rank
1
10
9
21
15
17
24
23
41
49
46
sub Index
7.1
6.1
6.3
5.4
5.8
5.6
5.1
5.2
4.3
4.1
4.2
NIC Index and sub index-INDIA
NIC Index
18.9(rank-38)
Innovation policy
4.8(rank-39)
Scientists/engineers 1.2(rank-59)
Cluster innovation
7.8(rank-31)
Linkages
5.2(rank-23)
Actors in NIS
Governments
(local,regional,national,international)-setting
policy directions
Bridging institutions-intermediaries between
governments and research performers.
Private enterprises & research institutes they
finance
Universities and institutions-provide key
knowledge and skills.
Other public and private organizations
(labs,TTOs,patent offices etc.)
NIS Linkages: Policy Formulation
Objective1-foster scientific research in Universities and
scientific institutions.
Objective2-promote interaction between private and
public institutions.
Objective3-Leverage technologies such as IT,
Biotechnology etc.
Objective4-strengthen enabling mechanisms relating to
technology development and absorption.
Objective5-promote international S&T cooperation.
NIS linkages: Strategy
Strategy1(Policyobjective1)-estb of research institute,
Setting up world class R&D centers.
Strategy2(Policyobjective2)-synergy between industry
&scientific research, increased R&D investments by
industry.
Strategy3(Policyobjective3)-capacity buiding,global
competitiveness.
Strategy4(Policyobjective4)-Technology transfer and
diffusion.
Strategy5(Policyobjective5)-MOUs,collaboration,foreign
R&D centers.
Policy impact:sectoral view
(Biotechnology)
R&D Institutions
Public-private partnership
Technology Transfer
Applications
S&T Cooperation
Foreign R&D Centres
R&D Institutions
CCMB
IMTECH
NII
NCBC
CBT
PGC/CHG
NBRC
DNA based research
Microbial Bioprocessing
Immunology research
Molecular Biology
Bioinformatics & Genomics
Genome research
Brain research
Public-Private partnership
Monsanto Research (R&D Center) @ IISc
Bangalore (plant genomics)
GENOMED(JV between CBT & Nicholas
Piramal) [pharmaco -genomics]
Institute of Bioinformatics and Applied
Biotechnology (Govt of Karnataka & ICICI)
Biotech Consortium India Ltd.
TATA-CSIR Initiative for Bio Suite.
Technology Transfer
Immunodiagnostics
Crop Biotechnology
Animal Biotechnology
Biomass
Biofertilizers
Industrial Biotech
Applications
(consumption of biotech products)
Human/Animal healthcare products
Agricultural products
Industrial products
Other Biotech products
S&T Cooperation
MOUs(Germany,Switzerland,USA,UK,
Sweden).
Coordinating G15 Nations in
establishment of Gene Banks.
(medicinal and aromatic plants)
More than 15 foreign R&D Centers.
Foreign R&D Centers
Astrazeneca,b’lore -dev of prescription
medicines
(cancer, neuroscience, cardiovascular, respiratory
&inflammation)
Gangagen Biotechnologies , b’lore-prevention & treatment
of bacterial functions
Novartis, Mumbai (Human vaccines)
Novo Nordisk, b’lore (Diabetes care)
R&D Millipore, b’lore (protein/DNA research)
Intervet India,pune (animal health products)
…………………………..and many more.
Policy Impact:sectoral view
(Nanotechnology)
R&D Institutions
Public-private partnership
Industry R&D
Applications
S&T Cooperation
R&D Institutions
Nanoparticles
IISc/IIT-K/NCL/TIFR
Carbon nanotubes JNCASR/NPL/NCL
DNA Biochips
IIT-B/CSIO
Nanocomposites IISc/IIT-M/IIT-R
MEMS
SSPL
Surface Engg
SINP
Molecular imprints
IICT
Public-Private Partnership
MEMS RESEARCH LAB
Collaboration between
Cranes software International Limited
& IISc Bangalore
Industry R&D
Biomix Network Limited, Mumbai
(Developing biotechnology tools)
Velbionanotech,Mumbai
(Bionanotechnology products)
Nano Tex LLc -dev centre in India.
Applications
Dabur and Shantha Biotech
(Using drug delivery applications on
commercial scale).
Raymonds and Grasim
(Using nano –chemicals).
Samsung and LG
(using nano-coating).
S&T Cooperation
US based Nano- tex planning an R&D
center in India.
Ranbaxy has already signed a deal
with Bayer.
Innovation tomorrow: Policy
Implications
3rd generation innovation policy
Technological capability development route
Technological learning processes
Capacity Building in IMTT: An IIFT
initiative
3rd generation policy
Core emphasis on innovation across.
Placing innovation at the heart of
policy areas shaping innovation
performance.
Developing interfaces that allow for
pooling of knowledge.
Developing interfaces that allow for
Experience learning.
Coordination of policy initiatives.
Technological capability
development routes
Reverse Value Chain
Reverse PLC
Process Specialist
Product pioneering
Application pioneering
Technological learning processes
Reverse value chain-learning by doing,
learning by transacting,R&D.
Reverse PLC-learning by doing, reverse
engineering, imitative R&D.
Process specialist-learning by doing,
learning by transacting,R&D.
Product pioneering- R&D,market
research.
Application pioneering-Technology
scanning, Integration with Domain
Knowledge.
Capacity Building in IMTT
An IIFT initiative
Developing masters program in innovation
management and technology transfer.
4 partners-UCE,UK; DMU, China; IEH, Poland;
IIFT, India.
Knowledge dissemination through workshops,
training sessions, forums.
Beneficiaries shall include
knowledge workers from academia, R&D, SMEs,
industry, policymakers.
THANK YOU